No Detail Found!

Synergistic effects of Zinc oxide nanoparticles and conventional antibiotics against methicillin resistant Staphylococcus aureus

Author(s)
Munazza Sharif Institute of Microbiology,University of Sindh-Jamshoro- Pakistan Division of BiomedicalScience and Biochemistry, Research School of Biology,The Australian National University, Canberra, ACT - Australia
Sarfraz Ali Tunio . Division of Biomedical Science and Biochemistry, Research School of Biology, The Australian National University,Canberra, ACT -,AustraliaAuthors' Affiliation:,Canberra, ACT -,Australia
Shaista Bano . Division of Biomedical Science and Biochemistry, Research School of Biology, The Australian National University,Canberra, ACT -,AustraliaAuthors' Affiliation:,Canberra, ACT -,Australia
Abstract
Background: Methicillin resistance in Staphylococcus aureus (MRSA) is creating crises in therapeutic options for the treatment of S. aureus associated infections, worldwide. Nevertheless, Zinc oxide ackground: Methicillin resistance in Staphylococcus aureus (MRSA) is creating crises in therapeutic nanoparticles (ZnO-NPs) are providing a source of an attractive broad-spectrum antibiotic. The aim of the present study was to investigate the synergistic effects of ZnO-NPs and antibiotics against mecA positive MRSA isolates. Methods: Antibiogram of S. aureus was determined by Kirby Baur disc diffusion assay. The minimum inhibitory concentration (MIC) of antibiotics and ZnO-NPs was determined by using the broth dilution method. The mecA gene in S. aureus was detected by PCR amplification with gene specific forward and reverse primers. The effects of subinhibitory concentration of ZnO-NPs on conventional antibiotics was determined by combined disk diffusion assay. Results: Out of two hundred clinical specimens, twenty-eight showed the growth of S. aureus. Antibiogram of the isolates showed that S. aureus have acquired resistance to the majority of the conventional antibiotics. However, no isolate showed resistance to vancomycin. The confirmed methicillin resistant S. aureus isolates were sensitive to ZnO-NPs. The antibacterial activity of ZnO-NPs appeared in a dose and time dependent manner since higher dose produced stronger effects in two hours than the effects produced from lower dose in three hours. Furthermore, ZnO-NPs enhanced the antibacterial activity of levofloxacin significantly (p < 0.001). Conclusions: S. aureus has acquired strong resistance to multiple antibiotics. ZnO-NPs have potential synergism with levofloxacin antibiotic against the multiple drug resistant S. aureus including MRSA.
Publication Details
Page(s) 167-171
DOI DOI not available
Published Journal: Advancements in life sciences, Volume: 8, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
levofloxacin, Combinational therapy, MRSA, Synergism
0

Citations

0

Downloads

41

Views